Vannin Neuropharma Consulting Limited in Canterbury, CT4 5BW

Description

Data updated on: 01-11-2023

This enterprise named Vannin Neuropharma Consulting was established on 2012-05-22 as a Private Limited Company. This firm's office can be reached at Canterbury on 4 De Havillands, Bekesbourne. Assuming you need to contact the company by post, the area code is CT4 5BW. The official registration number for Vannin Neuropharma Consulting Limited is 08079342. This firm's declared SIC number is 74909 - Other professional, scientific and technical activities not elsewhere classified. The business most recent accounts were submitted for the period up to 2023-05-31 and the most current confirmation statement was filed on 2023-05-22.

There's a single director presently leading this company, namely Eric K. who has been executing the director's tasks for 12 years. The company had been controlled by Sandra D. till 2022-10-10.

Eric K. is the individual who has control over this firm, owns over 3/4 of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2013-05-31	2014-05-31	2015-05-31	2016-05-31	2017-05-31	2018-05-31	2019-05-31	2020-05-31	2021-05-31	2022-05-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth		69 210	95 757	121 611

Balance Sheet
Current Assets				128 563	121 215	120 956	120 890	120 817	120 558	120 497
Net Assets Liabilities				121 611	121 187	120 763	120 504	120 193	119 757	119 278
Cash Bank In Hand	31 883	81 542	103 425	128 563
Net Assets Liabilities Including Pension Asset Liability	24 956	69 210	95 757	121 611
Tangible Fixed Assets			495	330

Capital & Reserves
Called Up Share Capital	100	100	100	100
Profit Loss Account Reserve	24 856	69 110	95 657	121 511
Shareholder Funds		69 210	95 757	121 611

Other Financial Data
Version Production Software								2 020	2 022	2 022
Accrued Liabilities Not Expressed Within Creditors Subtotal				493	193	193	193	238	300	418
Creditors				6 789			193	386	501	801
Fixed Assets				330	165
Net Current Assets Liabilities	24 956	69 210	95 262	121 281	121 215	120 956	120 697	120 431	120 057	119 696
Total Assets Less Current Liabilities				122 104	121 380	120 956	120 697	120 431	120 057	119 696
Capital Employed	24 956	69 210
Creditors Due Within One Year	6 927	12 332	8 163	7 282
Number Shares Allotted	100	100	100	100
Number Shares Allotted Increase Decrease During Period	100	100
Par Value Share	1	1	1	1
Share Capital Allotted Called Up Paid	100	100	100	100
Tangible Fixed Assets Additions			660
Tangible Fixed Assets Cost Or Valuation			660	660
Tangible Fixed Assets Depreciation			165	330
Tangible Fixed Assets Depreciation Charged In Period			165	165
Value Shares Allotted Increase Decrease During Period	100

Company staff

Eric K.

Role: Director

Appointed: 22 May 2012

Latest update: 15 March 2024

People with significant control

Eric K.

Notified on 22 May 2016

Nature of control:

over 3/4 of shares

Sandra D.

Notified on 22 May 2016

Ceased on 10 October 2022

Nature of control:

substantial control or influence

Accounts Documents

Account next due date	28 February 2025
Account last made up date	31 May 2023
Confirmation statement next due date	05 June 2024
Confirmation statement last made up date	22 May 2023

Annual Accounts 2 July 2013
Start Date For Period Covered By Report	2012-06-01
End Date For Period Covered By Report	2013-05-31
Date Approval Accounts	2 July 2013
Annual Accounts 30 September 2014
Start Date For Period Covered By Report	2013-06-01
Date Approval Accounts	30 September 2014
Annual Accounts 1 October 2015
Start Date For Period Covered By Report	1 June 2014
End Date For Period Covered By Report	31 May 2015
Date Approval Accounts	1 October 2015
Annual Accounts 6 July 2016
Start Date For Period Covered By Report	1 June 2015
End Date For Period Covered By Report	31 May 2016
Date Approval Accounts	6 July 2016
Annual Accounts
Start Date For Period Covered By Report	1 June 2016
End Date For Period Covered By Report	31 May 2017
Annual Accounts
Start Date For Period Covered By Report	1 June 2017
End Date For Period Covered By Report	31 May 2018
Annual Accounts
Start Date For Period Covered By Report	1 June 2018
End Date For Period Covered By Report	31 May 2019
Annual Accounts
Start Date For Period Covered By Report	1 June 2019
End Date For Period Covered By Report	31 May 2020
Annual Accounts
Start Date For Period Covered By Report	1 June 2020
End Date For Period Covered By Report	31 May 2021
Annual Accounts
Start Date For Period Covered By Report	1 June 2021
End Date For Period Covered By Report	31 May 2022
Annual Accounts
Start Date For Period Covered By Report	1 June 2022
End Date For Period Covered By Report	31 May 2023
Annual Accounts
End Date For Period Covered By Report	31 May 2014

Vannin Neuropharma Consulting Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Eric K.

Sandra D.

People with significant control

Eric K.

Sandra D.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies